• 2021
  Passaes C, Delagreverie HM, Avettand-Fenoel V, David A, Monceaux V, Essat A, Müller-Trutwin M, Duffy D, De Castro N, Wittkop L, Rouzioux C, Molina JM, Meyer L, Delaugerre C, Sáez-Cirión A, , Ultrasensitive Detection of p24 in Plasma Samples from People with Primary and Chronic HIV-1 Infection., J Virol 2021 06; 95(14): e0001621.
• 2020
  Passaes C, Millet A, Madelain V, Monceaux V, David A, Versmisse P, Sylla N, Gostick E, Llewellyn-Lacey S, Price DA, Blancher A, Dereuddre-Bosquet N, Desjardins D, Pancino G, Le Grand R, Lambotte O, Müller-Trutwin M, Rouzioux C, Guedj J, Avettand-Fenoel V, Vaslin B, Sáez-Cirión A, , Optimal Maturation of the SIV-Specific CD8+ T Cell Response after Primary Infection Is Associated with Natural Control of SIV: ANRS SIC Study., Cell Rep 2020 09; 32(12): 108174.
• 2020
  Mikhailova A, Valle-Casuso JC, David A, Monceaux V, Volant S, Passaes C, Elfidha A, Müller-Trutwin M, Poyet JL, Sáez-Cirión A, , Antiapoptotic Clone 11-Derived Peptides Induce In Vitro Death of CD4+ T Cells Susceptible to HIV-1 Infection., J Virol 2020 07; 94(14): .
• 2020
  Allouch A, Di Primio C, Paoletti A, Lê-Bury G, Subra F, Quercioli V, Nardacci R, David A, Saïdi H, Cereseto A, Ojcius DM, Montagnac G, Niedergang F, Pancino G, Saez-Cirion A, Piacentini M, Gougeon ML, Kroemer G, Perfettini JL, , SUGT1 controls susceptibility to HIV-1 infection by stabilizing microtubule plus-ends., Cell Death Differ. 2020 Jun; (): .
• 2017
  Passaes CPB, Bruel T, Decalf J, David A, Angin M, Monceaux V, Muller-Trutwin M, Noel N, Bourdic K, Lambotte O, Albert ML, Duffy D, Schwartz O, Sáez-Cirión A, , Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents., J Virol 2017 03; 91(6): .
• 2016
  Angin M, Wong G, Papagno L, Versmisse P, David A, Bayard C, Muylder BC, Besseghir A, Thiébaut R, Boufassa F, Pancino G, Sauce D, Lambotte O, Brun-Vézinet F, Matheron S, Rowland-Jones SL, Cheynier R, Sáez-Cirión A, Appay V,, Preservation of Lymphopoietic Potential and Virus Suppressive Capacity by CD8+ T Cells in HIV-2-Infected Controllers, J. Immunol. 2016 Aug;.
• 2016
  Noel N, Peña R, David A, Avettand-Fenoel V, Erkizia I, Jimenez E, Lecuroux C, Rouzioux C, Boufassa F, Pancino G, Venet A, Van Lint C, Martinez-Picado J, Lambotte O, Sáez-Cirión A, Prado JG,, Long-term Spontaneous control of HIV-1 relates to low frequency of infected cells and inefficient viral reactivation, J. Virol. 2016 Apr; 90(13):6148-58.
• 2016
  Hamimi C, David A, Versmisse P, Weiss L, Bruel T, Zucman D, Appay V, Moris A, Ungeheuer MN, Lascoux-Combe C, Barré-Sinoussi F, Muller-Trutwin M, Boufassa F, Lambotte O, Pancino G, Sáez-Cirión A, , , Dendritic Cells from HIV Controllers Have Low Susceptibility to HIV-1 Infection In Vitro but High Capacity to Capture HIV-1 Particles., PLoS One 2016 ; 11(8): e0160251.
• 2015
  Frange P, Faye A, Avettand-Fenoël V, Bellaton E, Descamps D, Angin M, David A, Caillat-Zucman S, Peytavin G, Dollfus C, Le Chenadec J, Warszawski J, Rouzioux C, Sáez-Cirión A, , HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report, Lancet HIV 2016 Jan;3(1):e49-54.
• 2014
  Allouch A, David A, Amie SM, Lahouassa H, Chartier L, Margottin-Goguet F, Barré-Sinoussi F, Kim B, Sáez-Cirión A, Pancino G, Reply to Pauls et al.: p21 is a master regulator of HIV replication in macrophages through dNTP synthesis block, Proc. Natl. Acad. Sci. U.S.A. 2014 Apr;111(14):E1325-6.
• 2013
  Allouch A, David A, Amie SM, Lahouassa H, Chartier L, Margottin-Goguet F, Barré-Sinoussi F, Kim B, Sáez-Cirión A, Pancino G, p21-mediated RNR2 repression restricts HIV-1 replication in macrophages by inhibiting dNTP biosynthesis pathway, Proc. Natl. Acad. Sci. U.S.A. 2013 Oct;110(42):E3997-4006.
• 2011
  Sáez-Cirión A, Hamimi C, Bergamaschi A, David A, Versmisse P, Mélard A, Boufassa F, Barré-Sinoussi F, Lambotte O, Rouzioux C, Pancino G,, Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers, Blood 2011 Jul;118(4):955-64.
• 2009
  Bergamaschi A, David A, Le Rouzic E, Nisole S, Barré-Sinoussi F, Pancino G, The CDK inhibitor p21Cip1/WAF1 is induced by FcgammaR activation and restricts the replication of human immunodeficiency virus type 1 and related primate lentiviruses in human macrophages, J. Virol. 2009 Dec;83(23):12253-65.
• 2009
  Carthagena L, Bergamaschi A, Luna JM, David A, Uchil PD, Margottin-Goguet F, Mothes W, Hazan U, Transy C, Pancino G, Nisole S, Human TRIM gene expression in response to interferons, PLoS ONE 2009;4(3):e4894.
• 2009
  Bergamaschi A, Ayinde D, David A, Le Rouzic E, Morel M, Collin G, Descamps D, Damond F, Brun-Vezinet F, Nisole S, Margottin-Goguet F, Pancino G, Transy C, The human immunodeficiency virus type 2 Vpx protein usurps the CUL4A-DDB1 DCAF1 ubiquitin ligase to overcome a postentry block in macrophage infection, J. Virol. 2009 May;83(10):4854-60.
• 2007
  Jacquot G, Le Rouzic E, David A, Mazzolini J, Bouchet J, Bouaziz S, Niedergang F, Pancino G, Benichou S, Localization of HIV-1 Vpr to the nuclear envelope: impact on Vpr functions and virus replication in macrophages, Retrovirology 2007;4:84.
• 2006
  David A, Sáez-Cirión A, Versmisse P, Malbec O, Iannascoli B, Herschke F, Lucas M, Barré-Sinoussi F, Mouscadet JF, Daëron M, Pancino G, The engagement of activating FcgammaRs inhibits primate lentivirus replication in human macrophages, J. Immunol. 2006 Nov;177(9):6291-300.
• 2003
  Scott-Algara D, Truong LX, Versmisse P, David A, Luong TT, Nguyen NV, Theodorou I, Barré-Sinoussi F, Pancino G, Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users, J. Immunol. 2003 Dec;171(11):5663-7.
• 2003
  Truong LX, Luong TT, Scott-Algara D, Versmisse P, David A, Perez-Bercoff D, Nguyen NV, Tran HK, Cao CT, Fontanet A, Follézou JY, Theodorou I, Barré-Sinoussi F, Pancino G, CD4 cell and CD8 cell-mediated resistance to HIV-1 infection in exposed uninfected intravascular drug users in Vietnam., AIDS 2003 Jul; 17(10): 1425-34.
• 2003
  Perez-Bercoff D, David A, Sudry H, Barré-Sinoussi F, Pancino G, Fcgamma receptor-mediated suppression of human immunodeficiency virus type 1 replication in primary human macrophages., J Virol 2003 Apr; 77(7): 4081-94.
• 2000
  Talwar GP, Raghuvanshi P, Mishra R, Banerjee U, Rattan A, Whaley KJ, Zeitlin L, Achilles SL, Barré-Sinoussi F, David A, Doncel GF, Polyherbal formulations with wide spectrum antimicrobial activity against reproductive tract infections and sexually transmitted pathogens, Am. J. Reprod. Immunol. 2000 Mar;43(3):144-51.
• 1994
  Gringeri A, Santagostino E, Mannucci PM, Tradati F, Cultraro D, Buzzi A, Criscuolo M, David A, Guillemot L, Barré-Sinoussi F, A randomized, placebo-controlled, blind anti-AIDS clinical trial: safety and immunogenicity of a specific anti-IFN alpha immunization, J. Acquir. Immune Defic. Syndr. 1994 Sep;7(9):978-88.